Ethel Tong

Publications

192

Citations

H-Index

1960

Active since

Affiliations

University at Buffalo, State University of New York(Current)

SRI International

Ethel Tong is an author at University at Buffalo, State University of New York specializing in medicinal chemistry, pharmacology, and natural sciences.

Top concepts

PharmacologyMedicinal ChemistryBiochemistryNatural SciencesMedicineDrug DiscoveryChemical BiologyDrug DevelopmentBiocatalysisPharmacotherapy

Publications per year

1960–1962

Publications

POTENTIAL ANTICANCER AGENTS.<sup>1</sup> LXVI. NON-CLASSICAL ANTIMETABOLITES. III.<sup>2</sup> 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASE

B. R. Baker, William W. Lee, Ethel Tong et al. · Journal of the American Chemical Society · 1961 · 72 citations

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +16

Potential Anticancer Agents --L. Non-Classical Antimetabolites--II. Some Factors in the Design of Exo-Alkylating Enzyme Inhibitors, partcularly of Lactic Dehydrogenase

B. R. Baker, William W. Lee, W. A. Skinner et al. · Journal of Medicinal Chemistry · 1960 · 62 citations

Pharmaceutical Science, Altmetric Attention Score, Chemical Biology +18

Non-classical antimetabolites. VI. 4-(Iodoacetamido)-salicylic acid, an exo-alkylating irreversible inhibitor

B. R. Baker, William W. Lee, Ethel Tong · Journal of Theoretical Biology · 1962 · 48 citations

Medicinal Chemistry, Non-classical Antimetabolites, Pharmacology +2

Non-classical antimetabolites. V. Further factors in the design of exo-alkylating enzyme inhibitors, particularly of lactic dehydrogenase

B. R. Baker, William W. Lee, Ethel Tong et al. · Journal of Theoretical Biology · 1962 · 10 citations

Medicinal Chemistry, Aldehyde Dehydrogenase, Biochemistry +9

Rows per page

1–4 of 4